3.230.173.188
dgid:
enl:
npi:0
-Advertisement-
Glaucoma
Industry News

Glaucoma Research Foundation to recognize Santen Pharmaceutical at Annual Gala

Posted on

Glaucoma Research Foundation (GRF) President and CEO Thomas M. Brunner announced today that Santen Pharmaceutical Co, will receive GRF’s highest honor, the Catalyst Award, at the Glaucoma 360 Annual Gala on February 2, 2023, in San Francisco.

Santen, a global specialized company focused solely on eye care, is being recognized for their steadfast commitment to bringing innovation to the field of glaucoma. “We are delighted to have an opportunity to highlight the Santen team and their work serving unmet patient needs through their development of innovative solutions to treat glaucoma and improve the quality of life for patients around the world,” said Brunner. Peter Sallstig, MD, MBA, the Global Head of Santen’s Product Development Division and the Chief Medical Officer will accept the award on behalf of Santen.

“Santen is extremely proud and honored to receive this prestigious award. Our team is guided by a passion for bringing innovation to eye care and contributing to the well-being of patients and their families worldwide. It has been a great pleasure to partner with Glaucoma Research over the past 20 years and support their many patient education and research initiatives,” said Dr. Sallstig.

“Santen aspires to create a world where each person can live their happiest life through the best vision experience and we will continue to help reduce the loss of social and economic opportunities resulting from eye conditions by providing solutions in ophthalmology, by promoting people to pursue eye wellness and by creating a society that is inclusive regardless of visual impairment,” Dr. Sallstig added.

The Annual Gala launches Glaucoma 360, a unique series of events held at the historic Westin St. Francis Hotel that includes the New Horizons Forum, a full-day meeting dedicated to innovations in glaucoma therapy and concludes with two continuing medical education symposia for ophthalmologists and optometrists. Mr. Brunner added, “Santen has been a generous supporter of Glaucoma 360 since our very first meeting in 2012 and has continued to partner with Glaucoma Research Foundation to help advance our mission to cure glaucoma and restore vision through innovative research. We are pleased that Dr. Sallstig and many Santen team members will join us for this special evening.”

All proceeds from Glaucoma 360 support Glaucoma Research Foundation’s research and education programs. To learn more about the February 2–4, 2023, events or to register, visit: www.glaucoma360.org.

Read the full press release here.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-